CSI

Cardiovascular Systems, Inc. is a medical device company focused on developing and commercializing minimally invasive treatment solutions for vascular diseases. Endovascular treatment of peripheral arterial disease (PAD) through interventional means was its initial area of focus. The company is committed to setting industry standards by ensuring safety and efficacy in medical devices through clinical rigor, continuous innovation, and definition-driven approaches to treating life. The company has developed patented orbital atherectomy technology for peripheral and coronary commercial applications.